1. Ahlenius S (1991) Pharmacological evaluation of new antipsychotic drugs. In: Willner P (ed) Behavioural models in psychopharmacology: theoretical, industrial, and clinical perspectives. Cambridge University Press, Cambridge, Mass, pp 311–330
2. Barnett A, Iorio LC, McQuade R, Chipkin RE (1988) Pharmacological and behavioral effects of D1 dopamine antagonists. In: Goldstein M, Fuxe K, Tabachnick I (eds) Central D1 dopamine receptors, advances in experimental medicine and biology, vol 235. Plenum Press, N.Y., pp 137–144
3. Casey DE (1992) Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys. Psychopharmacology 107:18–22
4. Coffin VL, Latranyi MB, Chipkin RE (1989) Acute extrapyramidal syndrome in cebus monkeys: development mediated by dopamine D2 but not D1 receptors. J Pharmacol Exp Ther 249:769–774
5. Damsma G, Robertson GS, Tham C-S, Fibiger HC (1991) Dopaminergic regulation of striatal acetylcholine release: importance of D1 andn-methyl-d-aspartate receptors. J Pharmacol Exp Ther 259:1064–1072